John C Reed

EVP, Innovative Medicine, R&D, Johnson & Johnson

Bought, 12 months

$0.0M

Sold, 12 months

$13.1M

Companies

Latest trade

Feb 17, 2026

Companies

Johnson & JohnsonEVP, Innovative Medicine, R&D −$17.3M

Trades

JNJ Sold 53,931 shares at $243.00 $13.1M Feb 17

JNJ Sold 21,721 shares at $192.71 $4.2M Oct 17

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.